NCT03140150 (SAFECARE) is a NA clinical trial of Follow-up by Carelink express in Telecardiology, sponsored by University Hospital, Brest.

Who is sponsoring NCT03140150?

NCT03140150 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT03140150?

Interventions in NCT03140150: Follow-up by Carelink express, Follow-up according to the usual recommendations.

What condition does NCT03140150 study?

NCT03140150 studies Telecardiology.

Is NCT03140150 still recruiting?

NCT03140150 is currently terminated. Last updated 10 January 2024.

Last reviewed 2024-01-10 · How we verify

NCT03140150: SAFECARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety Acceptability and Benefits of Tracking Cardiac Pacemakers by Carelink Express

Terminated NA Last updated 10 January 2024

What this trial tests

NA trial testing Follow-up by Carelink express in Telecardiology in 50 participants. Terminated before completion.

Timeline

26 December 2017

Primary endpoint
13 November 2023

13 November 2023

Quick facts

Lead sponsor	University Hospital, Brest
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	device feasibility
Enrollment	50
Start date	26 December 2017
Primary completion	13 November 2023
Estimated completion	13 November 2023
Sites	2 locations across France

Drugs / interventions tested

Follow-up by Carelink express
Follow-up according to the usual recommendations

Conditions studied

Telecardiology — all drugs for Telecardiology →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Telecardiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Follow-up strategy for patients implanted with a pacemaker.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03140150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 10 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03140150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing